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Summary
Objective: The aggrecan proteoglycan is a major component of articular cartilage and supports the biomechanical
function of this tissue. A variable number tandem repeat (VNTR) polymorphism has been discovered recently in a
region of the human aggrecan gene that codes for the chondroitin sulfate attachment sites. We examined whether
alleles of this polymorphism displayed a non-random association with bilateral hand or knee osteoarthritis (OA) in
men from the Baltimore Longitudinal Study of Aging (BLSA).
Design: DNA was obtained from 93 Caucasian men, aged 60 and above, who had bilateral hand and standing knee
radiographs read for changes of OA. The DNA was analyzed by polymerase chain reaction (PCR) and/or Southern
blotting for the presence of the VNTR alleles.
Results: Bilateral hand OA and knee OA were present in 46 and 30% of the men respectively. The following
distribution of alleles was observed: allele 33 (0.5%), 29 (2.2%), 28 (31.7%), 27 (43.0%), 26 (16.7%), 25 (3.2%) , 22 (2.2%)
and 19 (0.5%). This distribution was similar to that detected in a random population of individuals from a separate
study. In multiple logistic regression analysis, adjusting for age and body mass index, the presence of allele 27 was
associated with bilateral hand OA with an odds ratio (OR) = 3.23 (95% confidence intervals (CI): 1.24–8.41). No other
alleles showed an association with bilateral hand OA and the association between allele 27 and bilateral knee OA
was not statistically significant (OR = 1.14; 95% CI: 0.45–2.88).
Conclusions: These data demonstrate the first association between a human aggrecan gene polymorphic allele and
hand OA. This finding supports the concept that genetic factors may play a role in the development and/or progression
of some forms of age-onset OA.
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Introduction
Osteoarthritis (OA) is a heterogeneous disease
that results from degradation of articular cartilage
in one or more diarthrodial joints accompanied by
changes in the subchondral bone and surrounding
joint capsule [1]. In the most common form of OA,
so-called idiopathic disease, pain and functional
impairment usually develop in the 5th or 6th
decade of life. The precise interplay of risk factors,
genetic or environmental, that influences the
development and progression of OA remains
unclear [2,3]. Several studies have demonstrated
familial aggregation of radiographic [4,5] and
clinically defined hand OA [6]. A large twin study
confirmed a strong genetic contribution to both
radiographic hand and knee OA [7]. Several
reports have identified and studied distinct
families in which individuals who present with
early-onset, polyarticular OA, with accompanying
mild chondrodysplasia have a single mutation in
exon 31 of the collagen II gene [8,9]. However, a
report on generalized OA and OA of the finger in
a Finnish population failed to demonstrate that a
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multiallelic polymorphism of the collagen II gene
was a causative factor for either [10]. Of course,
other alleles of the collagen II gene could be
involved and the identification of causative gene
defects with reduced penetrance could be masked
by a high frequency of normal alleles at the
population level. However, it is reasonable to
consider the possibility that other genes coding for
other cartilage proteins, such as aggrecan, carti-
lage oligometric protein (COMP), and minor
collagens (e.g., Types V, IX, XI) could play a role
in the genetic predisposition toward generalized,
primary OA, and may even play a role in the
development of the more common age-onset
idiopathic form of the disease.
Aggrecan is the most abundant non-collagenous
component of articular cartilage [11]. The protein
core of aggrecan is extensively modified with
keratan sulfate and chondroitin sulfate glycos-
aminoglycan (GAG) side chains that provide a high
concentration of negative charges which act to
provide cartilage with its compressive properties
and resiliency. Thus, one important function of
aggrecan is to maintain the high water content
characteristic of cartilage; the molecule may serve
other functions that involve interacting with other
matrix molecules and low molecular weight
growth factors. Recently a polymorphism has been
identified in the region of the human aggrecan
gene that codes for the GAG attachment site with
at least 13 alleles so far observed [12]. The putative
proteins expressed by the various alleles would
differ in the number of repeats present in the
chondroitin sulfate attachment region and differ in
the overall length of the core protein. Given the
relatively rare occurrence of this type of polymor-
phism and the fact that aggrecan is critical to
cartilage function, we designed a study to
determine if any of the polymorphic alleles were
associated with primary OA in individuals partici-
pating in the Baltimore Longitudinal Study of
Aging (BLSA). Here we report that the most
common allele, A27, shows an association with
bilateral hand OA in this population.
Methods
subjects and disease definitions
The subjects were participants in the BLSA, a
multidisciplinary research project conducted at
the Gerontology Research Center of the National
Institute on Aging located in Baltimore, Maryland
[13]. Participants are self-recruited, community-
dwelling volunteers; over 80% rate their health
status as good or excellent. They are of middle-to-
upper middle-class socioeconomic status: over 90%
are employed in professional, managerial or other
white collar professions, over 70% have at least a
baccalaureate degree, and over 70% rate their
financial situation as comfortable or better.
Participants board at the Gerontology Research
Center for 2.5 days during which time they undergo
biomedical, physiologic and psychologic testing;
these visits occur every 2 years, however, not all
tests are performed at each visit.
Bilateral postero-anterior hand and bilateral
weight-bearing antero-posterior knee radiographs
were taken at a single biennial visit between 1984
and 1991. All radiographs were read in 1992–93 by
one trained investigator, blinded as to subject,
using the Kellgren–Lawrence scales as described
in the Atlas of Standard Radiographs [14]. The
joint groups read for OA included both knees, and
the distal interphalangeal (DIP) and proximal
interphalangeal (PIP) joints, and the first carpo-
metacarpal joint (CMC1) of both hands. Each joint
was assigned a Kellgren–Lawrence grade of 0
(normal) through 4 (severe). Definite OA was
defined as Kellgren–Lawrence grade 2 or higher
changes.
The criteria for inclusion in this analysis were
that skin fibroblast samples had been obtained,
that both hand and knee X-rays were available and
had been read for radiographic hand and knee OA,
and that the subjects were 60 years of age or older
at time of X-ray. The minimum age was set at 60
years based on the assumption that if the subject
were to have ideopathic age-onset OA, it would
have appeared by age 60; given that this is a
community-dwelling population, we would expect
few cases of primary or generalized OA, or
early-onset disease. Because so few women in the
BLSA meeting the other criteria had had fibroblast
samples archived, the study was limited to men in
the BLSA.
OA cases were defined as those having bilateral
disease. For the purpose of this study, bilateral
hand OA is defined as Kellgren–Lawrence grade 2
or higher disease in at least two of the three joint
groups on both hands, with symmetry of involve-
ment. Bilateral knee OA is defined as Kellgren–
Lawrence OA grade 2 or higher in both the right
and left knees. Subjects with unilateral OA were
considered controls for the present analyses.
determination of polymorphism
The appropriate fibroblast samples were ob-
tained from the Coriell Institute which maintains
archival material from the BLSA. The fibroblasts
were expanded in culture with standard tissue
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culture techniques and DNA was extracted and
purified using Qiagen columns. The aggrecan gene
contains a large exon (exon 12) of at least 3.5 kb
[15,16] which encodes the entire GAG attachment
region of the core protein (Fig. 1). This region
consists of numerous repeated sequences, includ-
ing a particularly conserved set of repeats in the
chondroitin sulfate attachment portion [17]. The
expressed variable number tandem repeat (VNTR)
polymorphism used in this study occurs in this
highly conserved repeat region, and results in
individuals with different length aggrecan core
proteins, and presumably differing chondroitin
sulfate content in their cartilage. The polymor-
phism was detected in genomic DNA using a
polymerase chain reaction (PCR) assay and
Southern blotting as described in detail elsewhere
[12], and briefly as follows. The sequence of
sense and antisense primers for PCR were
5'-TAGAGGGCTCTGCCTCTGGAGTTG-3' and 5'-
AGGTCCCCTACCGCAGAGGTAGAA-3', respect-
ively. PCR amplification was carried out in 50 ml
solution containing 100 ng genomic DNA, 50 pmol
of each primer, 0.2 mm deoxynucleotide triphos-
phate (dNTP), 1.5 mm MgCl2, 50 mm KCl, 10 mm
Tris–HCl buffer (pH 8.3), 1% Triton X-100 and 2.5 U
Taq polymerase. Amplification proceeded for 29
cycles with denaturation at 95° C for 0.5 min,
annealing at 67° C for 0.5 min, and extension at
72° C for 1.5 min. PCR products were separated on
1% agarose gels and visualized by ethidium
bromide staining. Several of the alleles differ by
only one repeat in size (59 bp), and care was taken
to identify these alleles using appropriate gels and
size markers (Fig. 2). Alleles were scored by two
independent readers with adjudication and the
study was conducted in a double-blind manner.
Occasionally some DNA samples did not give
adequate PCR results, and these were analyzed by
Southern blotting, as described in detail elsewhere
[12]. Briefly, genomic DNA was cut with HaeIII,
fractionated on agarose gels, transferred to nylon
membrane by capillary blotting (Zetaprobe GT,
BioRad) and fixed by vacuum baking, 80° C for 2 h.
Filters were hybridized with a probe recognizing
the VNTR region of the cloned cDNA and washed
using standard conditions as recommended by
BioRad.
Statistics
Data were analyzed using the Statistical Analy-
sis System Version 6.06 (SAS Institute Inc., Cary,
N.C.). Mean values of age and body mass index by
presence of allele were compared using Student’s
t-tests, with statistical significance inferred as
P Q 0.05. The distribution of bilateral hand OA by
presence of allele, and bilateral knee OA by
presence of allele, was tested using chi-square
models, with statistical significance inferred as
P Q 0.05. The association of bilateral hand OA and
of bilateral knee OA with each allele was tested
using multiple logistic models analysis (PROC
LOGISTIC in SAS), with adjustment for differ-
ences in age and body mass index, to obtain odds
ratios (OR) and 95% confidence intervals (95%CI).
Results
A total of 93 Caucasian men met the criteria for
inclusion in this study. The mean age ( 2 s.d.) of
this group was 72.0 2 7.1 years, and the mean
( 2 s.d.) body mass index was 25.8 2 3.5 kg/m2.
Bilateral hand OA was present in 43 (46%) of the
men; bilateral knee OA was present in 28 (30%)
(Table I). Among the controls, 31 (33%) had
Fig. 1. A diagram of the core protein of the human aggrecan gene. The solid line is the portion of the protein containing
the chondroitin sulfate (CS) attachment sites and is encoded by exon 12. The VNTR (solid rectangle) is located within
this region and consists of a variable number of repeats of a 19 amino acid motif ranging from 13 to 33 that will result
in a difference in the overall length of the protein and number of CS attachment sites. The various alleles can be
detected by PCR using a primer set that flanks the polymorphic region or by probing a Southern transfer of genomic
DNA digested with HaeIII (see methods). The globular domains are labeled as G1, G2, and G3 and the keratan sulfate
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Fig. 2. PCR analysis of aggrecan alleles in three
individuals from the BLSA. Lane 1: fxHaeIII and kHD3
markers: Lane 2: 123 bp DNA ladder; Lane 3: allele
combination 28/25; Lane 4: allele combination 26/22;
Lane 5: allele combination 29/26; Lane 6: 124 bp DNA
ladder.
Fig. 3. Distribution of eight alleles of the aggrecan
VNTR polymorphism in men in the BLSA.
form, and in combination with alleles 28 and 26
accounts for approximately 85% of the genotype of
the population. This distribution is very similar to
what has been reported for an independent
population [12].
The distribution of alleles was compared
between cases with bilateral hand OA and controls
without bilateral hand OA (Table II). These
distributions were significantly different (x2
7df = 3.9, P Q 0.05) with an over-representation of
the A27 allele in the cases of bilateral hand OA.
Allele 27 shows a significant association
(OR = 3.23, 95% CI: 1.24–8.41) with bilateral hand
OA after adjustment for age and BMI using logistic
regression. Table III demonstrates that no signifi-
cant association was observed between any of the
alleles and bilateral knee OA.
We further explored the association between
allele 27 and bilateral hand OA by considering a
possible dose effect of this allele. In 68 men,
including the 30 men heterozygous for allele 27, but
excluding the 25 participants homozygous for
allele 27, we found an association between the
presence of allele 27 and bilateral hand OA
(OR = 3.08, 95%CI: 0.98–9.63), after adjustment for
unilateral hand OA, and 16 (17%) had unilateral
knee OA: 19 (20%) had no hand OA, 49 (52%) had
no knee OA, and only 11 (12%) had no OA at
either site.
A total of 13 alleles have so far been observed for
the aggrecan VNTR12 and eight of these alleles are
present in the included population (Fig. 3). Allele
27 (containing 27 repeats) is the most common
Table I
Distribution of bilateral hand and knee osteoarthritis, age, and body mass index (BMI) in men from
the BLSA
All Bilateral hand OA Bilateral knee OA
Control Case Control Case
N (%) 93 50 (53.8%) 43 (46.2%) 65 (69.9%) 28 (30.1%) Age (years)
BMI (kg/m2) 25.97 2 3.51 26.2 2 3.9 25.7 2 2.9 25.7 2 3.8 26.6 2 2.6
t!test difference between cases and controls\ PQ 9[90[
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Table II
Distribution of alleles of the aggrecan polymorphism and
bilateral hand OA in men from the Baltimore Longitudi-
nal Study of Aging
Allele N Cases: N (%) Controls: N (%)
A33 1 0 (0.0) 1 (1.0)
A29 4 2 (2.3) 2 (2.0)
A28 59 21 (24.4) 38 (38.0)
A27 80 45 (52.3) 35 (35.0)
A26 31 14 (16.3) 17 (17.0)
A25 6 3 (3.5) 3 (3.0)
A22 4 1 (1.2) 3 (3.0)
A19 1 0 (0.0) 1 (1.0)
Total N 186 86 100
and knee OA [18–24]. The occurrence of OA in the
hand is common in this population: indeed 90% of
women, and 70% of men aged 60 and above have
definite OA in at least one joint [18,19]. As our case
definition, we chose individuals who had definite
radiographic OA in two or three hand joint groups
bilaterally. The rationale for this definition was to
maximize the possibility that we were studying a
disease process that had a genetic basis and was
less likely to be due to traumatic insult. Indeed,
using this same definition, we have demonstrated
that there is familial aggregation of hand OA in
the BLSA participants [4]. Since the controls in
this study were not all free of OA at these or
possibly other joint sites, our analysis focuses on
an association with a severe subset of hand OA.
The aggrecan polymorphism occurs in exon 12
that codes for the chondroitin sulfate attachment
domain. This region of the protein is a repeating
motif consisting of a pattern of different amino
acids which bracket the serine–glycine pair that
designate where the GAG is attached. The
variation in the gene will result in different
numbers of repeats in the expressed protein
ranging from 13 to 33, which will influence the
length of the core protein and, presumably, the
extent of modification by GAGs. The frequency of
the alleles in the BLSA population followed
essentially a normal distribution. This distribution
was similar to that which was reported for an
independent population [12], suggesting that the
BLSA population did not have an unusual
frequency of alleles. Since the occurrence of
bilateral hand OA is relatively common in this
population, and taking into account the distri-
bution of the alleles, we anticipated that any
differences in allele frequencies that were observed
would be with either a set of the more rare alleles
or one of the more common alleles. In fact, the most
common allele (allele 27) was over-represented in
the case group as compared to the control. Alleles
28 and 26 differ from allele 27 by only one repeat
unit each, and to date no mechanism has been
described to explain how a single repeat difference
could directly relate to the occurrence of hand OA.
Interestingly, the homozygous allele 27 genotype is
only slightly more strongly associated with the
case group than the heterozygous genotypes that
contain one allele 27. This suggests that one dose
of this form of the protein is sufficient to bring
about the effect.
We did not observe an association between allele
27 (or any other allele) and bilateral knee OA. This
might suggest that processes contributing to the
disease might differ between the two joint groups.
It is important to note, however, that the number
differences in age and body mass index. Further,
when we included the allele 27 homozygotes, and
excluded allele 27 heterozygotes, we found a
stronger association between allele 27 and bilat-
eral hand OA (OR = 3.98, 95%CI: 1.23–12.88), after
adjustment for differences in age and body mass
index. While the association is stronger in the
homozygous participants than in the heterozygous
participants, there is not a twofold increase in the
odds ratio. However, because of the prevalence of
this allele, nearly a third of all participants were
excluded from each model, lessening the power of
this analysis.
Discussion
VNTR polymorphisms occurring in coding
regions are relatively rare. Since this VNTR was
reported in a gene that encoded a protein critical
to the function of cartilage, it was reasonable to
consider the possibility that one or more alleles
might associate (positively or negatively) with the
occurrence of OA.
We utilized the BLSA to initially explore this
possibility. This population has been well studied
with respect to both the occurrence of hand and
knee OA, and risk factors and predictors of hand
Table III
Distribution of alleles of the aggrecan polymorphism and
bilateral knee OA in men from the Baltimore Longitudi-
nal Study of Aging
Allele N Cases: N (%) Controls: N (%)
A33 1 0 (0.0) 1 (0.8)
A29 4 1 (1.8) 3 (2.3)
A28 59 16 (28.6) 43 (33.1)
A27 80 25 (44.6) 55 (42.3)
A26 31 12 (21.4) 19 (14.6)
A25 6 1 (1.8) 5 (3.8)
A22 4 1 (1.8) 3 (2.3)
A19 1 0 (0.0) 1 (0.8)
Total (N) 186 56 130
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of cases of bilateral knee OA is smaller than the
number of cases with bilateral hand OA, so that we
may have inadequate power to detect a significant
association with knee OA. Therefore it will be
important to extend the study for the knee joint
before any definitive conclusions can be drawn.
The observed association of a relatively com-
mon, late onset disease with the most common
allele of aggrecan is not surprising when one
considers that the aggrecan polymorphisms occur
in the population in a normal distribution, and are
apparently rather benign or innocuous in their
consequence. A subtle phenotype such as suscepti-
bility to late onset arthritis would not undergo any
evolutionary selective pressure, and a common
disease would require a common allele. One
prediction from this association would be that age
of onset of OA, or severity of OA in age-matched
controls, would follow a similar normal distri-
bution in the population; and that some of the
outlying aggrecan alleles would associate with the
more extreme examples of arthritis susceptibility
or resistance. A much larger population would be
needed to test this hypothesis.
The molecular basis for this observed associ-
ation is a matter of conjecture, but may be as
simple as a difference in matrix charge density due
to different chondroitin sulfate content of the
allelic proteoglycans. This molecule undergoes
complex modification and the size, number, and
degree of sulfation of the chondroitin sulfate
chains on aggrecan can all vary; such a model will
require extensive testing. The aggrecan VNTR
polymorphism, although it has arisen most likely
by unequal crossing over, is stable over several
generations within CEPH (Centre Etude Polymor-
phisme Humaine) family members [12], and has not
been seen to undergo any changes in culturing of
the numerous cell lines used for CEPH DNA
preparation [12]. This study differs from the
common use of polymorphisms strictly as mapping
tools in that allelic variants used as markers here
confer altered protein structure and are, in fact,
candidate alleles for the disease. However, the
possibility exists that a particular aggrecan allele
is merely the background upon which some other
causative mutation has arisen, perhaps in aggre-
can itself. This possibility seems unlikely given
that the relative instability of the repeat region
over evolutionary time should disperse the
causative mutation into other polymorphic alleles.
A further complication is that the scoring of
genotypes is based on VNTR length, and it is
possible that alleles of the same length arose
independently and have different sequences in the
VNTR region. There may thus be a subset of the 27
alleles which are causative or associated with a
causative mutation due to sequence differences
rather than differences in the absolute number of
repeats. However, limited sequencing of several
specific alleles revealed only minor differences in
the number of the four basic repeat units [12].
Despite these caveats, our initial hypothesis that
these allelic differences directly contribute to OA
susceptibility is supported by this study and more
direct tests are now required and justified.
These findings add to the number of genetic
alleles or polymorphisms which have been associ-
ated with radiographic OA in populations [25–28].
The observation of an association between a
polymorphic allele of the aggrecan gene and a form
of idiopathic OA is intriguing for several reasons.
First, it suggests that another cartilage matrix
protein besides collagen may contribute to the
genetic predisposition for developing OA. Second,
since the mechanism is not obvious, its elucidation
may enable the development of novel therapeutic
approaches for disease modification. Finally, it is
further evidence that this common age-associated
disease has a definable molecular basis.
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